You still need protein, fiber, hydration, and flavor
Image Credit: zimmytws / Shutterstock A recent review published in The Nurse Practitioner highlights the expanding clinical role of glucagon-like peptide-1 receptor agonists (GLP-1RAs), which have also drawn widespread media attention for their rapid weight-loss effects
In contrast, studies on the HCG diet have shown more variable results, with weight loss typically ranging from 5-10% over similar durations
We acknowledge that the impact in the near term is likely to be limited, given that drug adoption will grow gradually, but we could see a longer-term impact as drug prevalence increases
Chemosphere 263 , 128346 (2021)
These therapies, primarily administered as subcutaneous injectables for ease of at-home use, act by mimicking the native GLP1 hormone, enhancing glucose-dependent insulin secretion, suppressing glucagon release, lowering HbA1c levels, and promoting weight loss - all while carrying a minimal risk of hypoglycemia when used alone